Fundamental - Factsheet
Help
AsiaMedic
ASIAMEDIC LIMITED
Quotes 10 Minutes Delayed. Updated at 18 Jan 2021 17:01
Last (SGD): 0.021 |
Change: - |
High: 0.021 |
Change (%): - |
Low: 0.021 |
Open |
0.021 |
Yesterday's Close |
0.021 |
Buy Price |
0.021 |
Sell Price |
0.022 |
Buy Volume ('000) |
408.2 |
Sell Volume ('000) |
2,130.0 |
Cumulative Volume ('000) |
894.8 |
Cumulative Value |
18,791 |
Latest News
-
30 Nov 2020 17:31
-
14 Aug 2020 17:53
-
11 Aug 2020 17:29
-
17 Jul 2020 17:18
-
15 Jul 2020 17:41
-
15 Jul 2020 17:38
-
19 Jun 2020 17:35
-
17 Jun 2020 18:08
View All News
Key Statistics
(SGD) a
|
-0.00053 |
(SGD) e |
-0.00143 |
(SGD) b |
0.0095 |
a
|
- |
f |
- |
b |
2.2105 |
(SGD) d
|
- |
Cash In Hand
(SGD) g |
0.0054 |
Issued & Paid-up Shares
c |
1,119,522,000 |
(%)
d
|
- |
Price / Cash In Hand
g |
3.889 |
Treasury Shares h |
100,000 |
- 75
Daysi |
1.293 |
- 75
Days(%)i |
5.94 |
Market Cap (M) |
23.510 |
- 500
Daysi |
1.167 |
- 500 Days
(%)i |
2.15 |
Enterprise Value (M) |
21.160 |
|
5 |
Exchange Code |
505 |
Par Value (
SGD
)
|
n.a. |
52 Weeks Volatility (%) |
123.3262 |
6-Month VWAP |
0.024 |
|
- |
Under CPF Investment Scheme (CPFIS) |
Yes |
Sector & Industry |
Health and Social Services
-
Medical/Nursing Services |
Category Classification |
Medical & Biotechnology |
Index Components |
FTSE ST Catalist Index |
Notes:
-
Based on latest Full Year results announcement, adjusted for the current number of shares.
-
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
-
-
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
-
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
-
Based on Trailing EPS.
-
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
-
Rounded to the nearest thousand. Updated on 18 Aug 2020.
-
Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.
Peer Comparison
Type |
Name |
Market |
Market Cap (M)a |
b
|
c
|
d
|
(%)d
|
Reference |
AsiaMedic |
SGX |
23.510 |
- |
- |
2.2105 |
- |
Industry |
Medical & Biotechnology
|
SGX |
935.857 |
22.986 |
21.618 |
1.3668 |
1.977 |
Medical/Nursing Services
|
SGX |
55.691 |
60.828 |
30.922 |
1.5050 |
1.825 |
Index |
FTSE ST Catalist Index
|
SGX |
57.483 |
30.063 |
88.683 |
1.3752 |
1.227 |
Local Peer |
Cordlife |
SGX |
96.742 |
14.949 |
12.625 |
0.7326 |
2.626 |
Local Peer |
Clearbridge |
SGX |
98.137 |
- |
- |
1.5868 |
- |
Local Peer |
Asian Healthcare |
SGX |
93.466 |
36.155 |
36.157 |
1.9807 |
0.732 |
Local Peer |
HC Surgical |
SGX |
68.851 |
19.683 |
10.874 |
3.4509 |
4.374 |
Local Peer |
Sing Paincare |
SGX |
40.415 |
21.511 |
21.520 |
2.7744 |
0.002 |
Local Peer |
Alliance HC |
SGX |
35.133 |
15.049 |
15.046 |
1.8989 |
2.012 |
Local Peer |
Medinex |
SGX |
30.178 |
8.300 |
8.300 |
1.9263 |
7.304 |
Local Peer |
RHT HealthTrust |
SGX |
15.417 |
- |
- |
0.9268 |
- |
Global Peer |
JD HEALTH |
HKEx |
463,007.398 |
- |
- |
-72.4717 |
- |
Global Peer |
FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV |
NYSE |
25,354.138 |
18.883 |
17.006 |
1.8812 |
1.171 |
Global Peer |
GUARDANT HEALTH INC |
NASDAQ |
15,924.604 |
- |
- |
14.5802 |
- |
Global Peer |
DAVITA INC |
NYSE |
13,300.000 |
16.400 |
15.933 |
8.4458 |
- |
Global Peer |
OAK STREET HEALTH INC |
NYSE |
12,848.227 |
- |
- |
27.9115 |
- |
Global Peer |
PA GOODDOCTOR |
HKEx |
97,404.921 |
- |
- |
9.3733 |
- |
Global Peer |
SONIC HEALTHCARE |
ASX |
16,116.361 |
30.538 |
30.538 |
2.8915 |
2.506 |
Global Peer |
NATERA INC |
NASDAQ |
10,258.047 |
- |
- |
19.1380 |
- |
Global Peer |
AMEDISYS INC |
NASDAQ |
9,642.678 |
76.027 |
58.049 |
12.7514 |
- |
Global Peer |
INVITAE CORP |
NYSE |
9,292.653 |
- |
- |
22.3085 |
- |
Other Global Peers |
CHEMED CORP (NYSE), LHC GROUP INC (NASDAQ), NEOGENOMICS INC (NASDAQ), 1LIFE HEALTHCARE INC (NASDAQ), ENSIGN GROUP INC (NASDAQ), ACADIA HEALTHCARE (NASDAQ), JXR (HKEx), SMILEDIRECTCLUB INC (NASDAQ), OPTION CARE HEALTH INC (NASDAQ), BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A (NASDAQ), MEDNAX INC (NYSE), ADDUS HOMECARE CORP (NASDAQ), HEALIUS LTD (ASX), CASTLE BIOSCIENCES INC (NASDAQ), GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), FULGENT GENETICS INC (NASDAQ), US PHYSICAL THERAPY (NYSE), PENNANT GROUP INC (NASDAQ), SVH (SET), ONTRAK INC (NASDAQ), RAM (SET), RADNET INC (NASDAQ), KPJ (Bursa), TIVITY HEALTH INC (NASDAQ), HANGER INC (NYSE), C-MER EYE (HKEx), UM HEALTHCARE (HKEx), Metro Healthcare Indonesia Tbk. (IDX), BIODESIX INC (NASDAQ), OCEANIA HEALTHCARE LTD (ASX), GLOBAL CORD BLOOD CORPORATION (NYSE), CARDIFF ONCOLOGY INC (NASDAQ), AMERICAN RENAL ASSOCS HLDGS INC (NYSE), EUROEYES (HKEx), VIRTUS HEALTH LIMITED (ASX), PROGENITY INC (NASDAQ), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), APTINYX INC (NASDAQ), SANARA MEDTECH INC (NASDAQ), OPTINOSE INC (NASDAQ), AKUMIN INC (NASDAQ), EXAGEN INC (NASDAQ), GBS INC (NASDAQ), CLOVER CORP (ASX), ONCOSEC MEDICAL INCORPORATED (NASDAQ), CRH MEDICAL CORP (NYSE American), KANGHUA HEALTH (HKEx), SILK LASER AUSTRALIA LTD (ASX), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), UMP (HKEx), PRO-DEX INC (NASDAQ), HEALTHIA LTD (ASX), RAILY AESMED (HKEx), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), ORTHOCELL LIMITED (ASX), BIOCEPT INC (NASDAQ), OPTIMAX (Bursa), GUARDION HEALTH SCIENCES INC (NASDAQ), MHCARE (Bursa), KDH (SET), CAPITAL SENIOR LIVING CORP (NYSE), BARD1 LIFE SCIENCES LTD (ASX), RMH HOLDINGS (HKEx), TOTAL BRAIN LTD (ASX), D (SET), HUMAN HEALTH (HKEx), IMAC HOLDINGS INC (NASDAQ), REPUBLIC HC (HKEx), SMILE (Bursa), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), LIFESPOT HEALTH LTD (ASX), MOHO RESOURCES NL (ASX), SMILES INCLUSIVE LTD (ASX) |
Notes:
-
For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is
the average market cap for that industry/index.
-
Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the
industry/index.
-
Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all
companies in the industry/index.
-
Industry/Index Dividend Yield is
calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
-
For Industry/Index calculation, data for foreign currency denominated companies will be converted to the
main market currency using the latest exchange rate.
-
Industry/Index/Peers data is updated daily.
-
Peers are sorted by market capitalisation and only details for the top 10 will be shown.
Total Shareholder Return
Period | Dividend Received | Capital Appreciation | Total Shareholder Return |
---|
Short Term Return |
5 Days |
- | -0.002 | | | -8.70 % |
10 Days |
- | +0.001 | | | +5.00 % |
20 Days |
- | - | | | - |
Medium Term Return |
3 Months |
- | -0.001 | | | -4.55 % |
6 Months |
- | -0.002 | | | -8.70 % |
1 Year |
- | +0.008 | | | +61.54 % |
Long Term Return |
2 Years |
- | -0.004 | | | -16.00 % |
3 Years |
- | -0.039 | | | -65.00 % |
5 Years |
- | -0.040 | | | -65.57 % |
Annualised Return |
Annualised |
- | - | | | -19.21 % |
Notes:
-
Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
-
Script dividends are ignored in this calculation.
Price Movements
1 Year Range |
0.005 - 0.035 |
Change From 1 Year Low |
+0.016 |
% Change From 1 Year Low (%) |
+320.00 |
Change From 1 Year High |
-0.014 |
% Change From 1 Year High (%) |
-40.00 |
2 Years Range |
0.005 - 0.035 |
Change From 2 Years Low |
+0.016 |
% Change From 2 Years Low (%) |
+320.00 |
Change From 2 Years High |
-0.014 |
% Change From 2 Years High (%) |
-40.00 |
5 Years Range |
0.005 - 0.100 |
Change From 5 Years Low |
+0.016 |
% Change From 5 Years Low (%) |
+320.00 |
Change From 5 Years High |
-0.079 |
% Change From 5 Years High (%) |
-78.89 |
Notes:
Price movements are based on adjusted historical data.
Company Background
Headquartered in Singapore and listed on the Catalist Board of the Singapore Stock Exchange, AsiaMedic Limited is a premier healthcare provider that focuses on the management of clinical services in the fields of disease prevention, early illness detection and advanced diagnostics. Its team of highly qualified and reputable professionals provides clinical and management services both in Singapore and overseas. The services provided by AsiaMedic include but are not limited to health-risk assessments and screening, general and subspecialty imaging such as MRI and CT Scans for cardiovascular, neuroradiological, ENT and musculoskeletal imaging; PET/CT imaging for diagnosis, staging, localisation and monitoring progress of cancer. Driven by its commitment to the core values of competence, care, convenience and collaboration, AsiaMedic has built up a strong brand name for delivering positive patient outcomes and high-quality care for its patients from Singapore and around the region. Apart from Singapore, AsiaMedic has a growing presence in key growth markets such as China, Indonesia, Vietnam and Russia. Recognising the increasing demand for quality healthcare services in Asia and the Middle East, AsiaMedic expanded into the provision of international healthcare consultancy and management services in 2009. As an endorsement of its strengths and track record in the regional healthcare services industry, AsiaMedic was awarded two high-profiled turnkey projects in Abu Dhabi by Mubadala Healthcare, a division of Mubadala Development Co. and owned by the Government of the Emirate of Abu Dhabi. The projects were successfully completed and handed over in early 2012. Having tested and proven its healthcare services business model in Singapore and the region, AsiaMedic is developing more innovative healthcare services in selected markets for its next stage of growth.
More Information Available
More information is available to our subscribers, including:
- Market Moving News from Dow Jones Newswires
- Consensus Estimates
- Dividend/Distribution History
- Financial Summary with Financial Period Comparison
- Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
- Events Calendar for Results Announcements, Ex-Dates etc
- Insider Buying and Selling Report
If you are an existing subscriber, please login. If not, read up on what
you are missing out in our Help Centre
and join us as a subscriber.
Disclaimer:
While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-
- no liability is accepted for any errors or inaccuracies resulting from your use of these features;
- many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.